Your Location：
Home >
Browse articles >
Risk Identification and Regulation for China's Anti-Commercial Bribery in Medical Device Procurement and Sales Industry
Chinese Medical Sciences Journal   Pages: 1-7(2025)
Updated：2025-05-24

    • Risk Identification and Regulation for China's Anti-Commercial Bribery in Medical Device Procurement and Sales Industry

    • “Reporting on the latest research in the medical device procurement and sales sector, the article introduces its research progress in the field of anti-commercial bribery. Expert xx established the preventive regulatory framework, which provides solutions to effectively reduce commercial bribery risks and prevent illegal and non-compliant conduct.”

    • DOI：10.24920/004450    

      CLC：

    • Received：17 December 2025，

      Accepted：11 March 2025，

      Published Online：31 May 2025，

    Scan QR Code

  • Fu Jie,Xu Jingyi,Wang Yue.Risk Identification and Regulation for China's Anti-Commercial Bribery in Medical Device Procurement and Sales Industry[J].Chinese Medical Sciences Journal, DOI：10.24920/004450.

  •  
  •  

0

Views

0

Downloads

0

CSCD

PlumX

>
Alert me when the article has been cited
Submit
Outline
No Sections

Related Articles

No data

Related Author

No data

Related Institution

No data
0